Appointment of Joint Corporate Broker and Joint Financial Adviser
05 2월 2025 - 9:00PM
Oxford, UK – 5 February 2025:
OXB (LSE: OXB), a quality and innovation-led cell and gene therapy
CDMO, today announces the appointment of Jefferies International
Limited ("Jefferies") as its Joint Corporate Broker and Joint
Financial Adviser, to work alongside RBC Capital Markets, with
immediate effect.
-Ends-
Enquiries:
OXB:
Sophia Bolhassan, Head of Investor
Relations – T: +44 (0) 1865 509 737 / E: ir@oxb.com
ICR Healthcare:T: +44
(0)20 3709 5700 / E: oxb@icrhealthcare.com
Mary-Jane Elliott / Angela Gray / Davide
Salvi
About OXB
OXB (LSE: OXB) is a
quality and innovation-led contract development and manufacturing
organisation (CDMO) in cell and gene therapy with a mission to
enable its clients to deliver life changing therapies to patients
around the world.
One of the original
pioneers in cell and gene therapy, OXB has more than 25 years of
experience in viral vectors; the driving force behind the majority
of cell and gene therapies. OXB collaborates with some of the
world's most innovative pharmaceutical and biotechnology companies,
providing viral vector development and manufacturing expertise in
lentivirus, adeno-associated virus (AAV), adenovirus and other
viral vector types. OXB's world-class capabilities span from early
stage development to commercialisation. These capabilities are
supported by robust quality-assurance systems, analytical methods
and depth of regulatory expertise.OXB offers a vast number of
unique technologies for viral vector manufacturing, including a 4th
generation lentiviral vector system (the Tetravecta™ system), dual
plasmid system for AAV production, suspension and perfusion process
using process enhancers and stable producer and packaging cell
lines.
OXB, a FTSE4Good
constituent, is headquartered in Oxford, UK. It has bioprocessing
and manufacturing facilities across Oxfordshire, UK, Lyon and
Strasbourg, France and near Boston, MA, US. Learn more at
www.oxb.com, and follow us on LinkedIn and YouTube.
Oxford Biomedica (LSE:OXB)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Oxford Biomedica (LSE:OXB)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
